Last edition
News about "Gastroesophageal Reflux Disease "
Alembic Pharmaceuticals Secures USFDA Nod for Key GERD Injection Drug
The drug is a therapeutic equivalent to Protonix I.V., originally developed by Wyeth Pharmaceuticals, and is used to manage gastroesophageal reflux disease (GERD), erosive esophagitis, and certain rare hypersecretion conditions like Zollinger-Ellison Syndrome in adults.
Gastroesophageal Reflux Disease | 02/04/2025 | By Aishwarya
Mankind Pharma Signs License Deal with Takeda to Commercialise Acidity Drug in India
Mankind Pharma has signed a non-exclusive patent licence agreement with Takeda Pharmaceuticals for commercialising acidity drug Vonoprazan in the Indian market.
Gastroesophageal Reflux Disease | 22/07/2024 | By Aishwarya | 206
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy